Skip to main content
Article thumbnail
Location of Repository

MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins

By Yu Lei, Chris B. Moore, Rachael M. Liesman, Brian P. O'Connor, Daniel T. Bergstralh, Zhijian J. Chen, Raymond J. Pickles and Jenny P.-Y. Ting
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2674933
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2003). A novel coronavirus associated with severe acute respiratory syndrome.
    2. (2008). A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress and JNK-dependent apoptosis. Biochim Biophys Acta.
    3. (2003). Aetiology: Koch’s postulates fulfilled for SARS virus.
    4. (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3.
    5. (2003). Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis.
    6. (2005). Apoptotic pathways: ten minutes to dead.
    7. (2008). C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9.
    8. (2002). CARD games in apoptosis and immunity.
    9. (2005). Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.
    10. (2007). Caspases in cell survival, proliferation and differentiation.
    11. (2003). Characterization of a novel coronavirus associated with severe acute respiratory syndrome.
    12. (2003). Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.
    13. (2007). Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death.
    14. (2008). Crystal structure of human IPS-1/ MAVS/VISA/Cardif caspase activation recruitment domain.
    15. (2007). Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor.
    16. (2005). Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.
    17. (2005). Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.
    18. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome.
    19. (2001). Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1.
    20. (2007). Induction of apoptosis by the severe acute respiratory syndrome coronavirus 7a protein is dependent on its interaction with the Bcl-XL protein.
    21. (2005). IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.
    22. (2008). IRF-3 activation by sendai virus infection is required for cellular apoptosis and avoidance of persistence.
    23. (2004). Major genetic marker of nidoviruses encodes a replicative endoribonuclease.
    24. (1998). NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint.
    25. (2001). NF-kappaB signaling pathways in mammalian and insect innate immunity.
    26. (2008). NLRX1 is a regulator of mitochondrial antiviral immunity.
    27. (1999). Nod1, an Apaf-1-like activator ofcaspase-9and nuclear factor-kappaB.
    28. (2001). Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NFkappaB.
    29. (2007). Open reading frame 8a of the human severe acute respiratory syndrome coronavirus not only promotes viral replication but also induces apoptosis.
    30. (2005). Pathogenesis of severe acute respiratory syndrome.
    31. (2007). Pekosz A
    32. (1995). Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.
    33. (2008). Regulation of mitochondrial antiviral signaling pathways.
    34. (1997). Regulators of apoptosis on the road to persistent alphavirus infection.
    35. (2007). Retinoic acid-inducible gene-I and interferon-beta promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3.
    36. (2008). SARS coronavirus and innate immunity.
    37. (2002). Sendai virus trailer RNA binds TIAR, a cellular protein involved in virus-induced apoptosis.
    38. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.
    39. (2005). Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.
    40. (2003). The Genome sequence of the SARS-associated coronavirus.
    41. (2000). The IRF-3 transcription factor mediates Sendai virus-induced apoptosis.
    42. (2001). The mitochondrial apoptosome: a killer unleashed by the cytochrome seas.
    43. (2000). The morphology of apoptosis.
    44. (2008). The NLR gene family: a standard nomenclature.
    45. (2004). The RNA helicase RIG-I has an essential function in double-stranded RNAinduced innate antiviral responses.
    46. (2006). The specific and essential role of MAVS in antiviral innate immune responses.
    47. (2006). Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS.
    48. (2002). Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection.
    49. (2005). VISA is an adapter protein required for virus-triggered IFN-beta signaling.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.